Abstract:BACKGROUND Acute pancreatitis is a rare extrapulmonary manifestation of coronavirus disease 2019 (COVID-19) but its full correlation with COVID-19 infection remains unknown. AIM To identify acute pancreatitis’ occurrence, clinical presentation and outcomes in a cohort of kidney transplant recipients with acute COVID-19. METHODS A retrospective observational single-centre cohort study from a transplant centre in Croatia for all adult renal transplant recipients with a functioning kidney allograft between March 2020 and August 2022 to record cases of acute pancreatitis during acute COVID-19. Data were obtained from hospital electronic medical records. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was proven by a positive SARS-CoV-2 real-time reverse transcriptase-polymerase chain reaction on the nasopharyngeal swab. RESULTS Four hundred and eight out of 1432 (28.49%) patients who received a renal allograft developed COVID-19 disease. The analyzed cohort included 321 patients (57% males). One hundred and fifty patients (46.7%) received at least one dose of the anti-SARS-CoV-2 vaccine before the infection. One hundred twenty-five (39.1%) patients required hospitalization, 141 (44.1%) developed pneumonia and four patients (1.3%) required mechanical ventilation. Treatment included immunosuppression modification in 233 patients (77.1%) and remdesivir in 53 patients (16.6%), besides the other supportive measures. In the study cohort, only one transplant recipient (0.3%) developed acute pancreatitis during acute COVID-19, presenting with abdominal pain and significantly elevated pancreatic enzymes. She survived without complications with a stable kidney allograft function. CONCLUSION Although rare, acute pancreatitis may complicate the course of acute COVID-19 in kidney transplant recipients. The mechanism of injury to the pancreas and its correlation with the severity of the COVID-19 infection in kidney transplant recipients warrants further research.

SARS-CoV-2 and the pancreas: What do we know about acute pancreatitis in COVID-19 positive patients?

Acute Pancreatitis may Occur in COVID-19 Patients with Clearance of SARS-CoV-2 in Lung: A Case Report

Acute pancreatitis in COVID-19 patients: true risk?

Pancreatic and Hepatic Injury in COVID-19: A Worse Prognosis in NAFLD Patients?

Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members

Uncovering the Potential Pathological Mechanism of Acute Pancreatitis in Patients with COVID-19 by Bioinformatics Methods

Duality of the association between COVID-19 and acute pancreatitis

Acute Pancreatitis As the Initial Manifestation in 2 Cases of COVID-19 in Wuhan, China

SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients

Acute Pancreatitis with Colonic Pseudo-obstruction in a Patient with COVID-19

Acute pancreatitis as a complication of acute COVID-19 in kidney transplant recipients

Liver diseases in COVID-19: Etiology, treatment and prognosis.

Novel Evidence of Acute Kidney Injury in COVID-19

International Survey on Severe Acute Respiratory Syndrome Coronavirus 2 and Acute Pancreatitis Co-occurrence in Children

Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications

Clinical characteristics and short-term outcomes of acute pancreatitis among patients with COVID-19

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19

SARS-CoV-2 Causes Acute Kidney Injury by Directly Infecting Renal Tubules

Infection with SARS-CoV-2 can cause pancreatic impairment

S2725 The Dual Assault of COVID-19: Hepatitis and Pancreatitis

A rare case of heterotopic pancreatitis and intestinal malrotation in a COVID-19 positive patient. COVID-19, causative or coincidence?